Ovarian
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. (NCT02734004) | AstraZeneca | 2016-03-17 |
| Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) (NCT02331251) | Western Regional Medical Center | 2014-12-01 |
| Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats (NCT01078662) | AstraZeneca | 2010-02-21 |
| Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer (NCT00888810) | Centre Francois Baclesse | 2008-03-01 |
| Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors (NCT00972205) | National Cancer Institute (NCI) | 2007-12-01 |
Track Ovarian automatically
Every clearance here is in the API, with alerts when new ones post.